CHICAGO, Aug. 25, 2011 /PRNewswire/ -- Zacks.com announces
the list of stocks featured in the Analyst Blog. Every day the
Zacks Equity Research analysts discuss the latest news and events
impacting stocks and the financial markets. Stocks recently
featured in the blog include: Monsanto Co. (NYSE: MON),
Dow Chemical Co. (NYSE: DOW) Syngenta AG (NYSE: SYT)
The Scotts Miracle-Gro Co. (NYSE: SMG) and NYSE Euronext
Inc. (NYSE: NYX).
(Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)
Get the most recent insight from Zacks Equity Research with the
free Profit from the Pros newsletter:
http://at.zacks.com/?id=5513
Here are highlights from Wednesday's Analyst Blog:
Monsanto Fears Losing Soy Market
Monsanto Co. (NYSE: MON) fears losing market share for
Roundup Ready Soy as Dow Chemical Co. (NYSE: DOW), the
biggest U.S. chemical maker, launches a genetically altered soybean
seed. Dow has planned to stop the use of Monsanto's widely licensed
technology as well, in the next generation of its Enlist
genetically modified soybeans.
The second generation of Enlist was recently submitted to the
U.S. Department of Agriculture for approval, which DOW expects to
achieve by "mid-decade". Once approved, these soybeans are
anticipated to substitute Monsanto's brand of glyphosate weedkiller
resistance for genetics, developed with M.S. Technologies LLC.
After Monsanto introduced its first Roundup Ready soybean in
1996, farmers started killing weeds easily through the system. But
since then, glyphosate use over Roundup Ready soybeans, corn,
cotton etc increased heavily and several species of crop-choking
weeds have become resistant to glyphosate-based Roundup.
Thereafter, these weeds started spreading rapidly through North and
South America.
With the launch of Enlist system, Dow sees replacement for
Monsanto's popular Roundup Ready system that accounts for more than
90% of U.S. soybean acreage as well as corn. Dow plans to target
customers using Monsanto's Roundup Ready seeds and Roundup
glyphosate weedkiller claiming that the U.S. farmers may now combat
weeds that are no longer killed by Roundup herbicide of
Monsanto.
Dow plans to start selling the first generation of Enlist
herbicide tolerance by 2013 in corn, 2015 in soybeans and 2016 in
cotton, pending regulatory approvals. Dow forecasts generation of
approximately $1.5 billion of profit
from herbicide and seed sales, which is anticipated to arrive as a
direct assault on the dominance of global seed leader Monsanto
Co.
Missouri-based Monsanto
Company, together with its subsidiaries, is a leading global
provider of agricultural products for farmers in the United States and internationally.
Monsanto's biotechnology research and rich product pipeline
provides strong competition to its peers, such as Dow, Syngenta
AG (NYSE: SYT), The Scotts Miracle-Gro Co. (NYSE: SMG)
and BASF SE.
We currently maintain a long-term Outperform recommendation on
the stock. Monsanto has a Zacks #2 Rank, which translates into a
short-term Buy rating (1-3 months).
NYSE-Boerse Merger Clears CFI
Yesterday, NYSE Euronext Inc. (NYSE: NYX) reached another
milestone on receiving a green signal for its merger with Deutsche
Boerse from the Committee on Foreign Investment (CFI) in the
US.
The CFI is a prime regulatory body in the US comprising
government officials representing the justice, commerce, state,
defense and homeland security departments. The board of CFI
scrutinizes all the international mergers made by the US-based
organizations.
Both NYSE and Deutsche Boerse successfully completed the first
lap when last month both the companies managed to attain the
consent from their respective majority shareholders. The sanction
from CFI has been a further impressive advancement in this merger
process.
While a roar of merger and acquisition activities took place in
the past three quarters, most of them never saw light due to the
regulatory snags, which reflects the significance of the regulatory
processes. The London Stock Exchange failed to take over
Canada's TMX Group and
Singapore stock exchange was also
unable to acquire Australian stock exchange owing to opposition
from regulatory authorities in both the countries.
Strongest Exchange Merger Ever
The NYSE-Deutsche Boerse merger is expected to be the most solid
business combination in the history of the global stock exchanges.
Based on 2010 net revenues, the prospective merger will earn
approximately 37% of total revenue from derivatives trading &
clearing, 29% in cash listings, trading & clearing, 20% in
settlement & custody and 14% in market data, index &
technology services.
Moreover, the prospective merger is expected to generate full
run-rate cost synergies of euro400
million ($580 million) along
with euro150 million ($218 million) in revenue synergies.
Want more from Zacks Equity Research? Subscribe to the free
Profit from the Pros newsletter: http://at.zacks.com/?id=5515.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and
qualitative analysis to help investors know what stocks to buy and
which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly
traded stocks. Our analysts are organized by industry which gives
them keen insights to developments that affect company profits and
stock performance. Recommendations and target prices are six-month
time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides
highlights of the latest analysis from Zacks Equity Research.
Subscribe to this free newsletter today:
http://at.zacks.com/?id=5517
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc.,
which was formed in 1978 by Leon
Zacks. As a PhD from MIT Len knew he could find patterns in
stock market data that would lead to superior investment results.
Amongst his many accomplishments was the formation of his
proprietary stock picking system; the Zacks Rank, which continues
to outperform the market by nearly a 3 to 1 margin. The best way to
unlock the profitable stock recommendations and market insights of
Zacks Investment Research is through our free daily email
newsletter; Profit from the Pros. In short, it's your steady flow
of Profitable ideas GUARANTEED to be worth your time! Register for
your free subscription to Profit from the Pros at
http://at.zacks.com/?id=5518.
Visit http://www.zacks.com/performance for information about the
performance numbers displayed in this press release.
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook:
http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before
making any investments. Nothing herein should be construed as an
offer or solicitation to buy or sell any security.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
SOURCE Zacks Investment Research, Inc.